Analysts and participants in the molecular biology tools industry are predicting a stronger pharmaceutical spending market in the second half of 2005, erasing earlier concerns about potential long-term revenue declines for the sector.

The predictions, which come after a turbulent beginning of the year marked by spotty R&D spending and volatile investment in molecular biology tools, may help buoy the multi-platform business sector covered by BioCommerce Week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.